Previous 10 | Next 10 |
2024-05-04 10:11:23 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-04-29 13:17:15 ET More on S&P 500 Index: Soft Landing On Track, With New All-Time Highs Ahead Yen Dumps Before It Jumps S&P 500: Trade Of The Year. Week Starting 29th April (Technical Analysis) Nasdaq, S&P, and Dow rise with the latest Fed de...
2024-04-28 15:24:54 ET Marathon Petroleum ( MPC ), 63 Coterra Energy ( CTRA ), 60 Info Tech... Read the full article on Seeking Alpha For further details see: With rate cuts pushed out, Goldman looks at quality stocks
2024-04-26 12:08:57 ET Shares of ResMed (NYSE: RMD) had soared 16.2% higher as of 11:50 a.m. ET on Friday. The big jump came after the healthcare technology company reported results on Thursday evening for its fiscal 2024 third quarter, which ended March 31. For the quarter, Res...
2024-04-26 07:04:05 ET ResMed's financial performance shows a 7% increase in net revenue for the three months ending March 31, 2024. RMD aims to accelerate growth through dedicated leadership in key areas. Management emphasizes global leadership in developing medical devices and software ...
2024-04-25 21:38:02 ET ResMed Inc. (RMD) Q3 2024 Earnings Conference Call April 25, 2024, 4:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial O...
2024-04-25 16:30:00 ET More on ResMed ResMed: Not A Sleeper ResMed Q3 2024 Earnings Preview Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down Seeking Alpha’s Quant Rating on ResMed Historical earnings data for ResMed ...
Year-over-year revenue grows 7% , operating profit up 25% , non-GAAP operating profit up 23% Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
2024-04-24 17:20:53 ET More on ResMed ResMed: Not A Sleeper Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down Mizuho sees ResMed as 'overwhelming beneficiary' of Philips consent decree Seeking Alpha’s Quant Rating on ResMed ...
News, Short Squeeze, Breakout and More Instantly...
ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 7.11% on an annualized basis producing an average annual return of 15.03%. ...
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio a...
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) Prevalence of OSA in the United States expected to increase 26.7%...